Patent Assignment
Reel/Frame 052761/0406
Assignment of Assignor's Interest
Recorded: 2020-05-27
Pages: 8
Assignors
YAO, YIHONG
Executed: 2020-05-20
LI, YANFENG
Executed: 2020-05-22
WEI, YUTIAN
Executed: 2020-05-21
ZHU, SHIGUI
Executed: 2020-05-21
YAO, XIN
Executed: 2020-05-20
HUANG, JIAQI
Executed: 2020-05-20
Assignees
SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
BUILDING 3, 85 FALADI ROAD, CHINA (SHANGHAI) PILOT FREE TRADE ZONE, PUDONG NEW AREA, SHANGHAI, 201210, CHINA
WUXI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
1ST FLOOR A AREA, 2ND FLOOR A AREA, 2ND FLOOR B AREA, BUILDING 7, 1699 HUISHAN ROAD, WUXI, JIANGSU, 214174, CHINA
Covered Property
(1)
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 18, 2021
From: SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 056586/0533 →
Assignment of Assignor's Interest
Jun 18, 2021
From: WUXI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 056586/0555 →
Assignment of Assignor's Interest
Dec 15, 2022
From: CELLULAR BIOMEDICINE GROUP HK LTD.
To: CELLULAR BIOMEDICINE GROUP INC.
Reel/Frame 062100/0469 →
Change of Name
Jan 19, 2024
From: CELLULAR BIOMEDICINE GROUP, INC.
To: ABELZETA INC.
Reel/Frame 066356/0108 →